F. Yan

发表

Global emission projections for the transportation sector using dynamic technology modeling ”

F. Yan, 2022 .

IBRUTINIB‐RITUXIMAB FOLLOWED BY REDUCED CHEMO‐IMMUNOTHERAPY CONSOLIDATION IN YOUNG, NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: a WINDOW OF OPPORTUNITY TO REDUCE CHEMO

F. Turturro, S. Huang, Suping Zhou, 2017 .